trending Market Intelligence /marketintelligence/en/news-insights/trending/sdzwcsqfqsb0i786liveiq2 content esgSubNav
In This List

Cooper Cos. appoints chief strategy officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cooper Cos. appoints chief strategy officer

Cooper Cos. Inc. appointed Holly Sheffield to the positions of executive vice president and chief strategy officer, effective June 4.

Sheffield will oversee the Pleasanton, Calif.-based medical device maker's corporate strategy, business development and global human resources.

She previously served as global head of medical technology in UBS Securities LLC 's healthcare banking group.

In addition, the company promoted Robert Auerbach to president of its CooperSurgical division on April 17. Auerbach succeeds Paul Remmell, who left the company after serving for 27 years.

Auerbach had been serving as executive vice president, chief strategy officer and chief medical officer of CooperSurgical.